Abstract
Infection remains the leading cause of complications and mortality in burn patients. This study investigates the distinct infection patterns between the burn intensive care unit (BICU) and burn common wards (BCW). Analyzing clinical samples from 2011 to 2019 in Southwest China, we found significant differences in pathogen distribution, sources, and antimicrobial resistance (AMR). BICU patients exhibited higher rates of Gram-negative bacteria and fungi compared to BCW. While Staphylococcus aureus dominated BCW, Acinetobacter baumannii was the most prevalent in BICU. Notably, multidrug-resistance (MDR) rates are higher in BICU, but the gap with BCW is narrowing, particularly due to the rise of carbapenem-resistant Klebsiella pneumoniae. These findings underscore the need for specialized infection-control strategies tailored to specific burn populations.
Introduction
For patients with severe burns, the loss of the skin barrier and subsequent immune suppression create an environment highly susceptible to life-threatening infections. While it is generally understood that Intensive Care Units (ICUs) face more complex microbial challenges than general wards, the specific evolutionary patterns of pathogens and their resistance profiles in burn-specific units have not been fully characterized. This study aims to bridge this gap by comparing the infection profiles and antimicrobial resistance (AMR) trends in a Burn Intensive Care Unit (BICU) and Burn Common Wards (BCW) over a nine-year period.
Methodology
This retrospective study analyzed clinical data from the Institute of Burn Research in Southwest China between January 1, 2011, and December 31, 2019.
- Sample Size: The study included 3,457 microbial strains from 1,159 BICU patients and 4,219 strains from 14,379 BCW patients, totaling 46,389 clinical specimens.
- Identification and Testing: Microbes were identified using the VITEK-2 compact system. Drug susceptibility was determined via the Minimum Inhibitory Concentration (MIC) method, adhering to Clinical and Laboratory Standards Institute (CLSI) guidelines.
- Data Analysis: Temporal trends and statistical significance were evaluated using WHONET 5.5 and SPSS.
Results and Discussion
Pathogen Distribution and Niche Specialization
The microbial "signatures" of the two environments are distinct. BICU samples showed a higher prevalence of Gram-negative bacteria (60.0% vs. 50.8%) and fungi (11.8% vs. 8.1%) compared to BCW. Acinetobacter baumannii emerged as the dominant pathogen in the BICU, particularly in invasive sites such as blood and sputum. Conversely, Staphylococcus aureus remained the primary threat in the BCW, mostly colonizing wound surfaces.
Variation in Infection Sources
The source of pathogens also varied significantly between the units. In the BCW, wound secretions accounted for the vast majority of isolates (86.6%). In the BICU, however, wound secretions represented less than half of the samples (44.9%), with a much higher incidence of infections originating from sputum, blood, and catheters.
Evolution of Antimicrobial Resistance
A critical finding of this study is the "closing gap" of resistance. While the BICU has historically been the primary reservoir for multidrug-resistant (MDR) organisms, MDR rates in the BCW are rising, narrowing the difference between the two units.
The most alarming trend is the meteoric rise of carbapenem resistance in Klebsiella pneumoniae. Resistance levels jumped from near zero in 2011 to 40% in both the BICU and BCW by 2019. Additionally, methicillin-resistant S. aureus (MRSA) remains nearly ubiquitous in the BICU at 94.2%, significantly higher than the 71.0% observed in the BCW.
Interestingly, the study noted a sharp decline in MDR Pseudomonas aeruginosa in the BICU, dropping from 85.7% to 24.5%. This may be attributed to improved environmental controls or displacement by other emerging resistant strains.
Conclusion
The distinct infection profiles and the rapid evolution of resistance—particularly the spread of carbapenem-resistant strains into common wards—highlight the urgent need for unit-specific antimicrobial stewardship. While bacterial resistance poses a grave challenge, the study found zero resistance to Amphotericin B among fungal isolates, maintaining it as a vital last line of defense. Future efforts should focus on multi-center longitudinal studies to further refine infection control protocols for diverse burn patient populations.
Summary updated